Arginine behaviour after arginine or citrulline administration in older subjects. Issue 3 (1st December 2015)

• Record Type: Journal Article
• Authors: Moinard, C.; Maccario, J.; Walrand, S.; Lasserre, V.; Marc, J.; Boirie, Y.; Cynober, L.
• Is Part Of: British journal of nutrition. Volume 115:Issue 3(2016)
• Page Start: 399
• Page End: 404
• Publication Date: 2015-12-01
• Subjects: Pharmacokinetics, -- Amino acids, -- Ornithine, -- Food supplements; Nutrition -- Periodicals; 572.4
• DOI: 10.1017/S0007114515004638
• Languages: English
• ISSNs: 0007-1145

Abstract

Abstract: Arginine (ARG) and its precursor citrulline (CIT) are popular dietary supplements, especially for the elderly. However, age-related reductions in lean body mass and alterations in organ functions could change their bioavailability. Pharmacokinetics and tolerance to amino acid (AA) loads are poorly documented in elderly subjects. The objective here was to characterise the plasma kinetics of CIT and ARG in a single-dosing study design. Eight fasting elderly men underwent two separate isomolar oral loading tests (10 g of CIT or 9·94 g of ARG). Blood was withdrawn over an 8-h period to measure plasma AA concentrations. Only CIT, ornithine and ARG plasma concentrations were changed. Volume of distribution was not dependent on AA administered. Conversely, parameters related to ARG kinetics were strongly dependent on AA administered: after ARG load, elimination was higher (ARG>CIT; P =0·041) and admission period+time at peak concentration was lower (ARG<CIT; P =0·033), and the combination of both phenomena results in a marked increase in ARG availability when CIT was administered (ARG<CIT; P =0·033) compared with ARG administration itself. In conclusion, a single CIT administration in the elderly is safe and well tolerated, and CIT proves to be a better in vivo ARG precursor than ARG itself in healthy elderly subjects.